檢索結果 - Monique Vogel

Refine Results
  1. 1

    A Comparison of Natural and Therapeutic Anti-IgE Antibodies 由 Monique Vogel, Paul Engeroff

    發表在 Antibodies (2024-07-01)
    獲取全文
    Article


  2. 2

    The Potential of Exosomes in Allergy Immunotherapy 由 Paul Engeroff, Monique Vogel

    發表在 Vaccines (2022-01-01)
    獲取全文
    Article


  3. 3

    Special Issue “Virus-Like Particle Vaccines” 由 Monique Vogel, Martin F. Bachmann

    發表在 Viruses (2020-08-01)
    獲取全文
    Article


  4. 4

    On the complexity of IgE: The role of structural flexibility and glycosylation for binding its receptors 由 Kevin Plattner, Kevin Plattner, Martin F. Bachmann, Martin F. Bachmann, Martin F. Bachmann, Monique Vogel, Monique Vogel

    發表在 Frontiers in Allergy (2023-03-01)
    獲取全文
    Article


  5. 5

    IgG in the control of FcεRI activation: a battle on multiple fronts 由 Federico Storni, Federico Storni, Monique Vogel, Monique Vogel, Martin F. Bachmann, Martin F. Bachmann, Paul Engeroff, Paul Engeroff

    發表在 Frontiers in Immunology (2024-01-01)
    獲取全文
    Article


  6. 6

    Successful Allergen-Specific Immunotherapy: Induction of Unresponsiveness by ‘Vaccination’ 由 Martin F. Bachmann, Monique Vogel, Daniel E. Speiser

    發表在 Vaccines (2023-12-01)
    獲取全文
    Article


  7. 7

    Economic Evaluation of Interventions for Prevention of Hospital Acquired Infections: A Systematic Review. 由 Habibollah Arefian, Monique Vogel, Anja Kwetkat, Michael Hartmann

    發表在 PLoS ONE (2016-01-01)
    獲取全文
    Article


  8. 8

    Dissecting the Interaction of FGF8 with Receptor FGFRL1 由 Lei Zhuang, Monique Vogel, Peter M. Villiger, Beat Trueb

    發表在 Biomolecules (2020-10-01)
    獲取全文
    Article


  9. 9

    On the role of allergen-specific IgG subclasses for blocking human basophil activation 由 Simon Zinkhan, Simon Zinkhan, Franziska Thoms, Gilles Augusto, Gilles Augusto, Gilles Augusto, Monique Vogel, Monique Vogel, Martin F. Bachmann, Martin F. Bachmann, Martin F. Bachmann

    發表在 Frontiers in Immunology (2022-10-01)
    獲取全文
    Article


  10. 10

    SARS-CoV-2 structural features may explain limited neutralizing-antibody responses 由 Martin F. Bachmann, Mona O. Mohsen, Lisha Zha, Monique Vogel, Daniel E. Speiser

    發表在 npj Vaccines (2021-01-01)
    獲取全文
    Article


  11. 11

    Anti-IL-6 Receptor Treatment in Giant Cell Arteritis Patients Reduces Levels of IL-1β-Receptor Antagonist but Not IL-1β 由 Joana J. da Costa, Lisa Christ, Peter M. Villiger, Monique Vogel, Martin F. Bachmann

    發表在 Rheumato (2024-03-01)
    獲取全文
    Article


  12. 12

    Low Iron Diet Improves Clinical Arthritis in the Mouse Model of Collagen-Induced Arthritis 由 Godehard A. Scholz, Sisi Xie, Tasneem Arsiwala, Daniel Guggisberg, Monique Vogel, Martin Bachmann, Burkhard Möller

    發表在 Cells (2024-10-01)
    獲取全文
    Article


  13. 13

    Histological evaluation of the distribution of systemic AA-amyloidosis in nine domestic shorthair cats 由 Valentina Moccia, Anne-Cathrine Vogt, Stefano Ricagno, Carolina Callegari, Monique Vogel, Eric Zini, Silvia Ferro

    發表在 PLoS ONE (2023-01-01)
    獲取全文
    Article


  14. 14

    Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes 由 Anne-Cathrine S. Vogt, Elisa S. Roesti, Mona O. Mohsen, Ainars Leonchiks, Monique Vogel, Martin F. Bachmann

    發表在 Vaccines (2021-11-01)
    獲取全文
    Article


  15. 15

    Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles 由 Xinyue Chang, Xuelan Liu, Mona O. Mohsen, Andris Zeltins, Byron Martina, Monique Vogel, Martin F. Bachmann

    發表在 Vaccines (2022-02-01)
    獲取全文
    Article


  16. 16

    Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies 由 Anne-Cathrine S. Vogt, Anne-Cathrine S. Vogt, Lukas Jörg, Lukas Jörg, Byron Martina, Byron Martina, Pascal S. Krenger, Pascal S. Krenger, Xinyue Chang, Xinyue Chang, Andris Zeltins, Monique Vogel, Monique Vogel, Mona O. Mohsen, Mona O. Mohsen, Martin F. Bachmann, Martin F. Bachmann, Martin F. Bachmann

    發表在 Frontiers in Immunology (2022-06-01)
    獲取全文
    Article


  17. 17

    A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain 由 Xinyue Chang, Andris Zeltins, Mona O. Mohsen, Zahra Gharailoo, Lisha Zha, Xuelan Liu, Senta Walton, Monique Vogel, Martin F. Bachmann

    發表在 Vaccines (2021-11-01)
    獲取全文
    Article


  18. 18

    Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron 由 Anne-Cathrine S. Vogt, Gilles Augusto, Byron Martina, Xinyue Chang, Gheyath Nasrallah, Daniel E. Speiser, Monique Vogel, Martin F. Bachmann, Mona O. Mohsen

    發表在 Vaccines (2022-05-01)
    獲取全文
    Article


  19. 19

    Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses 由 Alessandro Pardini, Dominik A. Rothen, Pascal S. Krenger, Anne-Cathrine Vogt, Romano Josi, Xuelan Liu, Kaspars Tars, Manfred Kopf, Monique Vogel, Martin F. Bachmann

    發表在 Viruses (2025-08-01)
    獲取全文
    Article


  20. 20

    AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate 由 Xuelan Liu, Xinyue Chang, Dominik Rothen, Mariliza Derveni, Pascal Krenger, Salony Roongta, Edward Wright, Monique Vogel, Kaspars Tars, Mona O. Mohsen, Martin F. Bachmann

    發表在 Vaccines (2021-04-01)
    獲取全文
    Article


檢索工具: